is januvia a glp-1 drug Understanding Side Effects & How to Manage Them Diabetes and Januvia (Sitagliptin)

doi: 10.1111/jdi.13005

The immune response in Graves disease is characterized by involvement of both Th2 and Th17 pathways, with interleukin (IL)-4, IL-6, and IL-17 contributing to B-cell activation and antibody production, while defects in immune checkpoints, such as impaired regulatory T-cell activity, promote loss of tolerance [17,18]

Comparative Effectiveness with Other Interventions To fully understand the role of GLP-1 RAs in pediatric obesity management, it is essential to compare their effectiveness with existing interventions

Reviewed by Dr

10 The US Patent and Trademark Office (USPTO), which issues patents, has recently embarked on a collaborative initiative with the FDA to better understand and promote the quality of patenting practices in the pharmaceutical industry